Cargando…

The effects of oral and vaporized cannabis alone, and in combination with alcohol, on driving performance using the STISIM driving simulator: A two-part, double-blind, double-dummy, placebo-controlled, randomized crossover clinical laboratory protocol

The legalization of cannabis for medicinal and non-medicinal purposes, and the corresponding increase in diversity of cannabis products, has resulted an urgent need for cannabis regulatory science. Among the most pressing needs is research related to impairment due to cannabis exposure, especially o...

Descripción completa

Detalles Bibliográficos
Autores principales: Zamarripa, C. Austin, Novak, Matthew D., Weerts, Elise M., Vandrey, Ryan, Spindle, Tory R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486093/
https://www.ncbi.nlm.nih.gov/pubmed/36147331
http://dx.doi.org/10.3389/fphar.2022.964749
_version_ 1784792201820110848
author Zamarripa, C. Austin
Novak, Matthew D.
Weerts, Elise M.
Vandrey, Ryan
Spindle, Tory R.
author_facet Zamarripa, C. Austin
Novak, Matthew D.
Weerts, Elise M.
Vandrey, Ryan
Spindle, Tory R.
author_sort Zamarripa, C. Austin
collection PubMed
description The legalization of cannabis for medicinal and non-medicinal purposes, and the corresponding increase in diversity of cannabis products, has resulted an urgent need for cannabis regulatory science. Among the most pressing needs is research related to impairment due to cannabis exposure, especially on driving performance. The present project was designed to evaluate the impact of oral and vaporized cannabis, when administered alone or in combination with alcohol, on simulated driving performance (STISIM driving simulator), cognitive/psychomotor ability, and field sobriety performance. Healthy adults will complete two, double-blind, double-dummy, placebo-controlled, randomized crossover clinical laboratory studies, one with oral cannabis (16 men/16 women) and the second with vaporized cannabis (16 men/16 women). In each study, participants will complete seven experimental sessions during which acute doses of placebo or high Δ9-THC cannabis containing 0, 10, or 25 mg Δ9-THC will be administered both alone and in combination with placebo or alcohol-containing beverages (target breath alcohol concentrations, BAC, of 0.0% or 0.05%). A positive control session (i.e., alcohol at target BAC of 0.08% with placebo cannabis) will also be completed. Simulated driving performance tests (available for download; see Methods), field sobriety assessments, subjective drug effect questionnaires, a mobile device impairment test (DRUID app), and collection of whole blood specimens will be completed repeatedly during each session. Linear mixed models will be used to test for differences across experimental conditions and a priori planned comparisons will be used to determine differences between conditions of interest (e.g., cannabis alone vs cannabis with alcohol). This research is designed to extend prior studies of cannabis and alcohol on driving performance by using oral and vaporized routes of cannabis administration. By increasing understanding of impairment associated with co-use of alcohol and these novel forms of cannabis, this research could inform impairment detection standards for cannabis and alcohol and have important implications for law enforcement, public policy decisions regarding accessibility of these substances, and education of the general population who may use cannabis and/or alcohol. Lastly, this manuscript provides interested researchers with access to the simulated driving scenarios and data extraction tools developed for this study as a means of facilitating future cross-study comparisons, which is important given the heterogeneity in methods used across laboratories in prior research.
format Online
Article
Text
id pubmed-9486093
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-94860932022-09-21 The effects of oral and vaporized cannabis alone, and in combination with alcohol, on driving performance using the STISIM driving simulator: A two-part, double-blind, double-dummy, placebo-controlled, randomized crossover clinical laboratory protocol Zamarripa, C. Austin Novak, Matthew D. Weerts, Elise M. Vandrey, Ryan Spindle, Tory R. Front Pharmacol Pharmacology The legalization of cannabis for medicinal and non-medicinal purposes, and the corresponding increase in diversity of cannabis products, has resulted an urgent need for cannabis regulatory science. Among the most pressing needs is research related to impairment due to cannabis exposure, especially on driving performance. The present project was designed to evaluate the impact of oral and vaporized cannabis, when administered alone or in combination with alcohol, on simulated driving performance (STISIM driving simulator), cognitive/psychomotor ability, and field sobriety performance. Healthy adults will complete two, double-blind, double-dummy, placebo-controlled, randomized crossover clinical laboratory studies, one with oral cannabis (16 men/16 women) and the second with vaporized cannabis (16 men/16 women). In each study, participants will complete seven experimental sessions during which acute doses of placebo or high Δ9-THC cannabis containing 0, 10, or 25 mg Δ9-THC will be administered both alone and in combination with placebo or alcohol-containing beverages (target breath alcohol concentrations, BAC, of 0.0% or 0.05%). A positive control session (i.e., alcohol at target BAC of 0.08% with placebo cannabis) will also be completed. Simulated driving performance tests (available for download; see Methods), field sobriety assessments, subjective drug effect questionnaires, a mobile device impairment test (DRUID app), and collection of whole blood specimens will be completed repeatedly during each session. Linear mixed models will be used to test for differences across experimental conditions and a priori planned comparisons will be used to determine differences between conditions of interest (e.g., cannabis alone vs cannabis with alcohol). This research is designed to extend prior studies of cannabis and alcohol on driving performance by using oral and vaporized routes of cannabis administration. By increasing understanding of impairment associated with co-use of alcohol and these novel forms of cannabis, this research could inform impairment detection standards for cannabis and alcohol and have important implications for law enforcement, public policy decisions regarding accessibility of these substances, and education of the general population who may use cannabis and/or alcohol. Lastly, this manuscript provides interested researchers with access to the simulated driving scenarios and data extraction tools developed for this study as a means of facilitating future cross-study comparisons, which is important given the heterogeneity in methods used across laboratories in prior research. Frontiers Media S.A. 2022-09-06 /pmc/articles/PMC9486093/ /pubmed/36147331 http://dx.doi.org/10.3389/fphar.2022.964749 Text en Copyright © 2022 Zamarripa, Novak, Weerts, Vandrey and Spindle. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Zamarripa, C. Austin
Novak, Matthew D.
Weerts, Elise M.
Vandrey, Ryan
Spindle, Tory R.
The effects of oral and vaporized cannabis alone, and in combination with alcohol, on driving performance using the STISIM driving simulator: A two-part, double-blind, double-dummy, placebo-controlled, randomized crossover clinical laboratory protocol
title The effects of oral and vaporized cannabis alone, and in combination with alcohol, on driving performance using the STISIM driving simulator: A two-part, double-blind, double-dummy, placebo-controlled, randomized crossover clinical laboratory protocol
title_full The effects of oral and vaporized cannabis alone, and in combination with alcohol, on driving performance using the STISIM driving simulator: A two-part, double-blind, double-dummy, placebo-controlled, randomized crossover clinical laboratory protocol
title_fullStr The effects of oral and vaporized cannabis alone, and in combination with alcohol, on driving performance using the STISIM driving simulator: A two-part, double-blind, double-dummy, placebo-controlled, randomized crossover clinical laboratory protocol
title_full_unstemmed The effects of oral and vaporized cannabis alone, and in combination with alcohol, on driving performance using the STISIM driving simulator: A two-part, double-blind, double-dummy, placebo-controlled, randomized crossover clinical laboratory protocol
title_short The effects of oral and vaporized cannabis alone, and in combination with alcohol, on driving performance using the STISIM driving simulator: A two-part, double-blind, double-dummy, placebo-controlled, randomized crossover clinical laboratory protocol
title_sort effects of oral and vaporized cannabis alone, and in combination with alcohol, on driving performance using the stisim driving simulator: a two-part, double-blind, double-dummy, placebo-controlled, randomized crossover clinical laboratory protocol
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486093/
https://www.ncbi.nlm.nih.gov/pubmed/36147331
http://dx.doi.org/10.3389/fphar.2022.964749
work_keys_str_mv AT zamarripacaustin theeffectsoforalandvaporizedcannabisaloneandincombinationwithalcoholondrivingperformanceusingthestisimdrivingsimulatoratwopartdoubleblinddoubledummyplacebocontrolledrandomizedcrossoverclinicallaboratoryprotocol
AT novakmatthewd theeffectsoforalandvaporizedcannabisaloneandincombinationwithalcoholondrivingperformanceusingthestisimdrivingsimulatoratwopartdoubleblinddoubledummyplacebocontrolledrandomizedcrossoverclinicallaboratoryprotocol
AT weertselisem theeffectsoforalandvaporizedcannabisaloneandincombinationwithalcoholondrivingperformanceusingthestisimdrivingsimulatoratwopartdoubleblinddoubledummyplacebocontrolledrandomizedcrossoverclinicallaboratoryprotocol
AT vandreyryan theeffectsoforalandvaporizedcannabisaloneandincombinationwithalcoholondrivingperformanceusingthestisimdrivingsimulatoratwopartdoubleblinddoubledummyplacebocontrolledrandomizedcrossoverclinicallaboratoryprotocol
AT spindletoryr theeffectsoforalandvaporizedcannabisaloneandincombinationwithalcoholondrivingperformanceusingthestisimdrivingsimulatoratwopartdoubleblinddoubledummyplacebocontrolledrandomizedcrossoverclinicallaboratoryprotocol
AT zamarripacaustin effectsoforalandvaporizedcannabisaloneandincombinationwithalcoholondrivingperformanceusingthestisimdrivingsimulatoratwopartdoubleblinddoubledummyplacebocontrolledrandomizedcrossoverclinicallaboratoryprotocol
AT novakmatthewd effectsoforalandvaporizedcannabisaloneandincombinationwithalcoholondrivingperformanceusingthestisimdrivingsimulatoratwopartdoubleblinddoubledummyplacebocontrolledrandomizedcrossoverclinicallaboratoryprotocol
AT weertselisem effectsoforalandvaporizedcannabisaloneandincombinationwithalcoholondrivingperformanceusingthestisimdrivingsimulatoratwopartdoubleblinddoubledummyplacebocontrolledrandomizedcrossoverclinicallaboratoryprotocol
AT vandreyryan effectsoforalandvaporizedcannabisaloneandincombinationwithalcoholondrivingperformanceusingthestisimdrivingsimulatoratwopartdoubleblinddoubledummyplacebocontrolledrandomizedcrossoverclinicallaboratoryprotocol
AT spindletoryr effectsoforalandvaporizedcannabisaloneandincombinationwithalcoholondrivingperformanceusingthestisimdrivingsimulatoratwopartdoubleblinddoubledummyplacebocontrolledrandomizedcrossoverclinicallaboratoryprotocol